At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study
Open Access
- 13 July 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 6 (1), 51
- https://doi.org/10.1186/1750-1172-6-51
Abstract
Objectives To assess associations between subcutaneous neurofibromas (SC-NFs) and internal neurofibromas in patients with neurofibromatosis type 1 (NF-1) and to determine whether the association between SC-NFs and peripheral neuropathy was ascribable to internal neurofibromas. Patients and methods Prospective multicentre case-control study. Between 2005 and 2008, 110 NF-1 adults having two or more SC-NFs were individually matched for age, sex and hospital with 110 controls who had no SC-NF. Patients underwent standardized MRI of the spinal cord, nerve roots and sciatic nerves and an electrophysiological study. Analyses used adjusted multinomial logistic regression (ORa) to estimate the risk of the presence of internal neurofibromas or peripheral neuropathies associated with patients presented 2 to 9 SC-NFs, at least 10 SC-NFs as compared to patients without any (referential category). Results Cases had a mean age of 41 (± 13) years; 85 (80%) had two to nine SC-NFs and 21 (19%) at least ten SC-NFs. SC-NFs were more strongly associated with internal neurofibromas in patients with ten or more SC-NFs than in patients with fewer NF-SCs (e.g., sciatic nerve, aOR = 29.1 [8.5 to 100] vs. 4.3 [2.1 to 9.0]). The association with SC-NFs was stronger for diffuse, intradural, and > 3 cm internal neurofibromas than with other internal neurofibromas. Axonal neuropathy with slowed conduction velocities (SCV) was more strongly associated with having at least ten SC-NFs (aOR = 29.9, 5.5 to 162.3) than with having fewer SC-NFs (aOR = 4.4, 0.9 to 22.0). Bivariate analyses showed that the association between axonal neuropathy with SCV and sciatic neurofibromas was mediated by the association between SC-NFs and sciatic neurofibromas. Conclusion The at-risk phenotype of NF-1 patients (i.e. NF-1 patients with SC-NFs) is ascribable to associations linking SC-NFs to internal neurofibromas at risk for malignant transformation and to axonal neuropathies with slowed conduction velocities. Axonal neuropathies with SCV are particularly common in patients with at least ten SC-NFs. Registration details ORPHA86301Keywords
This publication has 15 references indexed in Scilit:
- Identification of Genes Potentially Involved in the Increased Risk of Malignancy in NF1-Microdeleted PatientsMolecular Medicine, 2010
- NF-1Score: A Prediction Score for Internal Neurofibromas in Neurofibromatosis-1Journal of Investigative Dermatology, 2010
- Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1British Journal of Dermatology, 2005
- Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patientsAmerican Journal of Medical Genetics Part A, 2004
- Neurofibromatosis 1-associated neuropathies: a reappraisalBrain, 2004
- Clinical Risk Factors for Mortality in Patients With Neurofibromatosis 1Archives of Dermatology, 2003
- Mortality in Neurofibromatosis 1: An Analysis Using U.S. Death CertificatesAmerican Journal of Human Genetics, 2001
- [Neurofibromatosis 1: recommendations for management].2001
- Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)Neurology, 1991
- NeurofibromatosisArchives of Neurology, 1988